Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.350
-0.160 (-10.60%)
At close: May 15, 2026, 4:00 PM EDT
1.376
+0.026 (1.94%)
Pre-market: May 18, 2026, 5:30 AM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $20.87 million as of May 18, 2026. Its market cap has increased by 4.47% in one year.
Market Cap
20.87M
Enterprise Value
22.56M
1-Year Change
4.47%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $20.87M, a decrease of -73.71%. That is a compound annual growth rate of -26.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 20.87M | 22.30% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 23.31M |
| VYNE Therapeutics | 22.33M |
| Longeveron | 19.63M |
| Curis | 19.60M |
| Pasithea Therapeutics | 19.46M |
| Citius Pharmaceuticals | 19.14M |
| Traws Pharma | 19.10M |
| AEON Biopharma | 18.98M |